Overcoming Access & Adoption Barriers for Novel Non-Opioid Pain Therapies, a Medical Affairs Perspective

• Discuss strategies to shift prescribing away from opioids
• Share evidence generation strategies to pair new developments with real world evidence
• Evaluating health economic studies to prove how this strategy can fit into the market landscape in a way that is cost effective

Speakers:

Lizandra Marcondes

Senior VP, Medical Affairs

Avertias Pharma